Effect of tegaserod in chronic constipation: A randomized, double-blind, controlled trial John F. Johanson, Arnold Wald, Gervais Tougas, William D. Chey, James S. Novick, Anthony J. Lembo, Fiona Fordham, Mary Guella, Brigitte Nault Clinical Gastroenterology and Hepatology Volume 2, Issue 9, Pages 796-805 (September 2004) DOI: 10.1016/S1542-3565(04)00356-8 Copyright © 2004 American Gastroenterological Association Terms and Conditions
Figure 1 Trial overview. Clinical Gastroenterology and Hepatology 2004 2, 796-805DOI: (10.1016/S1542-3565(04)00356-8) Copyright © 2004 American Gastroenterological Association Terms and Conditions
Figure 2 Complete spontaneous bowel movement responder rates during weeks 1–4 (primary efficacy variable) and weeks 1–12. Clinical Gastroenterology and Hepatology 2004 2, 796-805DOI: (10.1016/S1542-3565(04)00356-8) Copyright © 2004 American Gastroenterological Association Terms and Conditions
Figure 3 Weekly responder rate throughout the study. Clinical Gastroenterology and Hepatology 2004 2, 796-805DOI: (10.1016/S1542-3565(04)00356-8) Copyright © 2004 American Gastroenterological Association Terms and Conditions
Figure 4 Time to first spontaneous bowel movement. Clinical Gastroenterology and Hepatology 2004 2, 796-805DOI: (10.1016/S1542-3565(04)00356-8) Copyright © 2004 American Gastroenterological Association Terms and Conditions